0000950170-24-064896.txt : 20240528
0000950170-24-064896.hdr.sgml : 20240528
20240528091123
ACCESSION NUMBER: 0000950170-24-064896
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240524
FILED AS OF DATE: 20240528
DATE AS OF CHANGE: 20240528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Culley Brian M
CENTRAL INDEX KEY: 0001310683
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12830
FILM NUMBER: 24986612
MAIL ADDRESS:
STREET 1: 6725 MESA RIDGE ROAD
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc.
CENTRAL INDEX KEY: 0000876343
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943127919
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: 5105213390
MAIL ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTIME INC
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
4
X0508
4
2024-05-24
0000876343
Lineage Cell Therapeutics, Inc.
LCTX
0001310683
Culley Brian M
2173 SALK AVENUE,
SUITE 200
CARLSBAD
CA
92008
true
true
false
false
President and CEO
false
Common Shares
2024-05-24
4
P
false
10000
1.05
A
154842
D
The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.05 to not more than $1.06. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
/s/ Brian M. Culley
2024-05-28